¤E¤Q¤­¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ¤ßŦ¬ì

(E) 1. ´N¹êÃÒÂå¾Ç½×ÂIClass 1(levelA)¹ï«DST¤Wª@¤ß¦Ù±ð¶ë¯g (Non-ST Elevation myocardialinfarction)¡A¤U¦C¦óªÌ¤£¥²¬O³w¦æ¦­´Áªý¤¶¤J³B¸m(early invasive management)¤§¾AÀ³¯g¡C
A.¦b¥ð®§ªvÀø¤¤¤´¦³¤ßµ±µh
B.¤ß¦¬ÁY¦åÀ£§C©ó90mmHg
C.«ùÄò©Ê¤ß«Ç§Ö¸õ
D.·s¥XSTªi¬q¤U¨I(ST depression)
E.cTnT 0.001 £gg/L
 
(C) 2.¯f¤H28·³¡A¨k©Ê¡A¥D¶Dªñ¤é¦³¹B°Ê©Ê©I§l§xÃø¡A¯f¤H¥X¥Í¤§¨è§Y¦]¤ßŦ°IºÜ¦í°|ªvÀø§ïµ½¡A¨ä«á¦¨ªø¥¿±`¡A²z¾ÇÀˬd¡G¦åÀ£118/80 mm Hg¡F¤ß¸õ74/¤À¡A¥¿±`³W«ß¡A¥k¤ßŦ·L¤j¡A¦ý¦bªÍ°Ê¯ß°Ï¦³²Ä¤G¦Ü¤T«×¤ßÁY®g¥X¤ßÂø­µ¡AS2¦³©T©w©Ê¤ÀµõÁn(fixed splitting of S2)¡AP2¼W Án¡A¥k¤U¤T¦yä°Ï¦³¤G«×¤ßµÎ¶©¶©ª¬¤ßÂø­µ(diastolic rumbling Murmur)¡A¤ß¹q¹Ï ¤Î¯Ý³¡X¥ú ¦p¹Ï¡C¥»¯f¤H³Ì¥i¯àªº¶EÂ_¬O¡G
A.¶}ºZ©ÊªÍ°Ê¯ßúPºÞ (Patent ductus arteriosus)
B.¤ß«Ç¤¤¹j¯Ê·l (Ventricular septal defect)
C.¤ß©Ð¤¤¹j¯Ê·l (Atrial septal defect)
D.¥D°Ê¯ß»Ö¤óÄu¯}µõ¨ì¥k¤ß«Ç (Ruptured sinus of Valsalva)
E.¥¿±`¤ßŦ (Normal heart)
 
(B) 3.¯f¤H48·³¡A¨k©Ê¡A®É¦³ÀY©üµÈ¯k¤§­W¡A¦bªÀ°Ï¶E©Ò¨ä¥ª¥kÂù¤â¦åÀ£¤À§O¬°124/68¤Î172/84 mmHg¡A¥ª¤W¤UªÏ¦åÀ£¬°120/70 ¤Î114/50 mmHg¡A¯f¤H¥D°Ê¯ß§e²{Âù¸­ª¬(Bicuspid)¡A¤ßŦ²z¾ÇÀˬd¦³¥ª¤ß«ÇªÎ¤j¡AS1±j¤O¡A¨Ã¦b«á­I³¡¦³¤ßÁY±j¥Xª¬ (ejectile)¤ßÂø­µ¡C
A.¥D°Ê¯ßä¯U¯¶ (Aortic stenosis)
B.¤j°Ê¯ß¯¶ÁY (Coarctation of the aorta)
C.ªÍ°Ê¯ßä¯U¯¶ (Pulmonic stenosis)
D.¤ß«Ç¤¤¹j¯Ê·l (Ventricular septal defect)
E.¶}ºZ©Ê°Ê¯ßúPºÞ (Patent ductus arteriosus)
 
(B) 4.¯f¤H18·³¡A¨k©Ê¡A¤Q¶µ¥þ¯à¹B°Ê¿ï¤â¡A¥D¶D¦b¿E¯P¹B°Ê«á±`¦³¼È°}©ü·w¤ÎÀY¯k¡A¦³¼Æ¦~¤§¤[¡A®a±Ú¤¤¦³¼Æ¤H¦b¦~»´°·§§ªº®É­Ô¬ðµMÖ`¦º( sudden death)¡A¤U¦C¦óªÌ¶EÂ_³Ì¤£¥²¦Ò¼{¡C
A.ªÎ«p©Ê¤ß¦Ù¯f(Hypertrophic Cardiomyopathy)
B.«a¤ß¯f(Acute Coronary Syndrome)
C.¥ý¤Ñ©Ê«aª¬°Ê¯ß°_·½²§±`(Coronary Artery Anomalies)
D.QT©µªø¯g­Ô¸s(Long QT Syndrome)
E.°¨µf¯g­Ô¸s(Marfan Syndrome)
 
(E) 5.´î¤Ö¤ß¦Ù¯Ó®ñ(myocardial oxygen consumption)ªº¦]¤l(determinants)¬OªvÀø¤ßµ±µh³Ì­«­nªº¨Ì¾Ú¡A¤U¦C¦óªÌ¤£¬O¦]¤l¡G
A.¤ß¸õ
B.¤ßÁY´Áªº¤ßŦ¾ÀÀ£(Wall tension during systole)
C.¤ßÁY¤O(Contractility)
D.²×ºÝ¤ßµÎ´Á¤§¤ß«Ç®e¿n(End-diastolic volume)
E.¤ß¦ÙªÎ«p«×
 
(B) 6.¤U¦C¦³Ãö¤ßªÍµd¿ô³N(CPR)¤§°O­z¡A¦óªÌ¬O¤£¥¿½Tªº¡H
A.¦³60%ªº¯f¤H°|¥~¦º¤`¡A¦³85-90%·|µo¥Í¤ß«ÇÅÖºûŸ°Ê(VF)©Î¤ß«Ç§Ö¸õ(VT)©M¤Î®ÉCPR«á¦s¬¡²v°ª¹F2-3­¿¡A¦]¦¹CPR¤§±À¼s»á¬°­«­n
B.¤ßŦ«ö¼¯(Cardiac Compression)/¤H¤u©I§l¤ñ¬O15¡G2
C.¨C¦¸¥hŸ¹qÀ»(Defibrillator)«áÀ³¦³2¤ÀÄÁªºCPR
D.§Ö³t¤ßŦ«ö¼¯©M¾A¶q¤Î¾A®Éªº´«®ð(Ventilation)¥i¼W¥[¦å²G¦^¬y
E.Âù¬Û¥hŸ(Biphasic defibrillator)¥iªv¦n85%ªº¤ß«ÇÅÖºûŸ°Ê(VF)
 
(C) 7.¯f¤H58·³¡A©ó¨Ó°|«e1¤p®É¦]¯Ý«e°Ï«æ¼@¤ß¯k¦Ó¦í°|¡A¦b¤U¦C¦óºØ¯f±¡¤U¡A¤£À³¨Ï¥ÎIV Nitroglycerin¡G
A.¥¼¦³¨Öµo¯g¤§«æ©Ê«e¾À¤ß¦Ù±ð¶ë¯g
B.¨ã¦³¶i®i©Ê¯Ê®ñÅܤƤ§¯f¯g
C.ÀVÀR¯ß«ã±i¡A¦åÀ£92/74mmHg¤Î¯Ý³¡²M´·¤£¨ãÆ{¦åÅܤƤ§«æ©Ê¤U¾À¤ß¦Ù±ð¶ë¯g
D.ªÍ³¡¤ô¸~
E.¦åÀ£180/112mmHg
 
(E) 8.¯f¤H74·³¡A¨k©Ê¡A¦³ªø¦~ªº³Ò°Ê­@¨ü¤£¨¬¤Î©I§l§xÃø¡A³Ìªñ¤@¬P´Á¯gª¬´c¤Æ¡A¬Æ¦Ü©]¶¡¦³«æ¼@«y¹Â¤ÎºÝ¥ß©Ê©I§l§xÃø¡A¦Ü«æ¶E³B¨DÂå®É¤§¤ß¹q¹Ï¦p¥Ü¡C³o­Ó¤ß¹q¹Ïªº«ß°ÊÅܤƬ°¦ó¡H
A.¥¿±`«ß°Ê
B.Äu©Ê¤ß¸õ¹LºC(Sinus bradycardia)
C.¥æ¬É©Ê«ß°Ê(Junction rhythm)
D.²Ä¤G«×©Ð«Ç¶Ç¾Éªýº¢(Second degree AV block)
E.§¹¥þ©Ð«Ç¶Ç¾Éªýº¢(Complete heart block)
 
(E) 9.¨k©Ê¯f¤H¡A²{¦~49·³¡A¥D¶Dªñ2­Ó¤ë¦³¶i®i©Ê´c¤Æªº¹B°Ê©I§l§xÃø¡A ¥L¤w¦³¤ßŦÂø­µ­Ý¦³©I§l§xÃø8¦~¡A¤@ª½¦b¤@®a¶E©Ò¶EÀø¡A²z¾Ç©Ò¨£¦åÀ£110/54¢PHg¡F¤ß¸õ60/¤À¡A¦³LV heave ¡A¦b¤ß¦y«e²Ä¤G«×¤ßµÎ¤¤´Á¶©¶©Âø­µ(Mid-diastolic rumbling murmur)¡A¦b¥D°Ê¯ß°Ï¦³²Ä¤G«×¦­´Á¤ßµÎÂø­µ(Early-diastolic blowing murmur )¡AS1´î®z¡AP2 ¥¿±`¡A¨S¦³S3¡A¨ä¥L¥¿±`¡C¯Ý³¡X¥ú¤Î¤ß¹q¹Ï ¡A¦p¹Ï¡C³o¦ì¯f¤H³Ì¥i¯àªº¤ßŦ¶EÂ_¬O¡G
A.¥¿±`¤ßŦ
B.¤G¦yä¯U¯¶(Mitral stenosis)
C.¤G¦y䳬Âꤣ¥þ(Mitral regurgitation)
D.¥D°Ê¯ßä¯U¯¶(Aortic stenosis)
E.¥D°Ê¯ß³¬Âꤣ¦X(Aortic regurgitation)
 
(C) 10.¦³Ãö¤ßŦ°IºÜªº°O­z¡A¤U¦C¦ó²Õªº»¡ªk¤£¥¿½T¡H(1).«æ©Ê¤ß¦Ù°IºÜ¦h¦]¤ß¦Ù±ð¶ëµo§@(2).¥k¤ß«Ç°IºÜ±`±`¬O¦]¥ª¤ß«Ç°IºÜ¤ÎªÍ°Ê¯ß°ªÀ£«P¦¨ (3).«O¯d¤ßÁY¥\¯àªº¥ª¤ß«Ç°IºÜ(Left ventricular failure with preserved left-ventricular ejection fraction)¦³¸û¤£¦nªº¹w«á (4).¤ò¦a¶À¥i§ïµ½¤ßŦ°IºÜ¯gª¬¡A¥ç¯à©µªø¹Ø©R (5).ACEªýÂ_¾¯¤ñAngiotensin II receptor antagonist¹ï¤ß¦Ù¦A¶ì©Ê(Remodeling)§ó¦n¡A©Ò¥H¬O¤ßŦ°IºÜªº¥²­nªvÀø
A.1¡Ï2
B.2¡Ï3
C.3¡Ï4
D.4¡Ï5
E.1¡Ï5
 
(C) 11.¤U¦C¦ó²ÕÃĪ«ªvÀø«æ©Ê¤ß¦Ù±ð¶ë¯f«áªºÄòµo©Ê¹w¨¾(Secondary Prevention)¬O¥¿½Tªº¡H(1).¥]¬AAspirin©ÎClopidogrel¤§§Ü¦åªOÃĪ«À³²×¨­ªA¥Î(life long) (2).¶tÂ÷¤lªýÂ_¾¯¹ï¤ßŦ°IºÜ¯f¤H¦³¦n³B¡AÀ³¦b¤ß¦Ù±ð¶ë¦­´Á´N¨Ï¥Î (3).£]-blocker¦³¹êÃÒ³ø§iÀ³¦b¨S¦³ÃĪ«°Æ§@¥Îªº¯f¤Hªø´Á¨Ï¥Î (4).ACEªýÂ_¾¯¦³¹w¨¾¤ß¦Ù¤£¨}¦A¶ì(Remodeling)¡A«e¾À¤ß¦Ù±ð¶ë©Î¥ª¤ß«Ç®g¥X³¡¤À¡Õ40%¤§¯f¤HÀ³¾¨¦­¨Ï¥Î (5).Nitroglycerin¥i§ïµ½«aª¬¦åºÞ¤º¤§¦å¬y¡A¥u¦³¯Ê®ñ¼xª¬¡A¤~¥i¦­´Á¨Ï¥Î
A.1¡Ï2¡Ï3
B.2¡Ï3¡Ï4
C.3¡Ï4¡Ï5
D.1¡Ï3¡Ï5
E.2¡Ï4¡Ï5
 
(E) 12.¤@¦ì65·³¨k©Ê±w¦³ºC©ÊµÇ°IºÜ¡A¤µ¦]µL¤O¡Aäú¤ß¡A¹Ã¦R¦Ü«æ¶E¨D¶E¡A¤U¦C¤ß¹q¹Ï©Ò¨£¡AÅã¥Ü¤U¦C¦óºØ¹q¸Ñ½è²§±`
A.§C¦å¹[ (hypokalemia)
B.§C¦å¶t(hypocalcemia)
C.°ª¦å¹[(hyperkalemia)
D.°ª¦å¶t(hypercalcemia)
E.°ª¦å¹[¤Î§C¦å¶t(hyperkalemia and hypocalcemia)
 
(B) 13.¤U¦C§Ü¦å¤pªO¾¯¤§§@¥Î¡A¦óªÌ¬°«D
A.Aspirin-§í¨îcycloxygenase¡A¦ÓªýÂ_thromboxane A2¤§²£¥Í
B.Clopidogrel-ATP¨ü®e¾¹(receptor)
C.Abciximab¡Atirofiban-glycoprotein IIb/IIIa¨ü®e¾¹¤§ªýÂ_¾¯¡AªýÂ_¦å¤pªO»Pfibrinogen¤§µ²¦X
D.Cilostazol-§í¨îphosphodiesterase III
E.¥H¤W¬Ò¥¿½T
 
(B) 14.¦b¤U¦CÀV³¡ÀR¯ßÀ£¤Wª@±¡ªp(A-E)¤¤¡A¦b¤U¦C¦óºØ±¡ªp¤U©|¥i¤p¤ß¨Ï¥Î§Q§¿¾¯
A.¤ß¥]Ån¶ñ¶ë (cardiac tamponade)
B.ºC©Ê³¬Âê¤ß¥]Ånª¢(chronic constrictive pericarditis)
C.«æ©Ê¤UÂz¤ß¦Ù±ð¶ë¦X¨Ö¥k¤ß«Ç±ð¶ë
D.¥k¤ß°IºÜ¯f¤H¸g±`¨Ï¥Î§Q§¿¾¯«á©|¦³¸}¸~¤ÎÀVÀR¯ßÀ£¤Wª@²{¶H¡A¦ý¯f¤H¯¸¥ß®ÉÀY·w¤Î²z¾ÇÀˬd½T»{¦³°_§¤©Ê§C¦åÀ£
E.«æ©ÊªÍ®ê¶ë¨Öµo¥k¤ß«Ç°IºÜ
 
(E) 15.¹ï©ó¥D°Ê¯ßäÄY­«¯U¯¶¡A¤U¦C±Ô­z¦óªÌ¬°«D
A.¯f¤H¨å«¬¤§¯gª¬¥]¬A©I§l§xÃø¡A©ü³Ö¤Î¯U¤ß¯g¡A¦ý¯f¤H¥ç¥i¯àµL¯gª¬
B.µo¥ÍÄY­«¤ß°IºÜ®É¡A¨ä¤ßÂø­µ¥i¯à¤£©úÅã
C.¯f¤H¦p¥X²{¥H¤W¯gª¬©Î¤ß°IºÜ«h¹w«á¤£¨Î¡A©Ò¥HÀ³«Øij§@¤ß¾ÉºÞÀˬd(¥]¬A«aª¬°Ê¯ßÄá¼v)¡A½T©w¶EÂ_«á§@¤¶¤J©ÊªvÀø(®ð²yÂX±i³N)©Î¥~¬ì佤¸m´«¤â³NªvÀø
D.¦b¦Ñ¤H¤§¶t¤Æ©Ê¥D°Ê¯ß¯U¯¶¡A¦]®ð²yÂX±i³N¤§³N«á¦A¯U¯¶²v°ª¡A¬G¥H¥~¬ì¤â³N¬°­º¿ï¤§ªvÀø
E.¥H¤W¬Ò¥¿½T
 
(D) 16.¯f¤H¦³¤ß©ÐŸ°Ê(atrial fibrillation)¡A¨ä¤ß«Ç³t²v(ventricular rate)¬ù¬°¨C¤ÀÄÁ150¡A¯f¤H¦X¨Ö¦³¤U¦C¯e¯f¡A¬°±±¨î¤ß«ß¨Ï¨ä´î½w¤§­º¿ïÃĪ«(A-D)¤¤¡A¦óªÌ°t¹ï¬°¤£¾A·í
A.¥Òª¬¸¢¥\¯à§Ü¶i-¤A«¬¥æ·P¯«¸gªýÂ_¾¯(propranolol)
B.®ð³Ý¯f-¶tÂ÷¤lªýÂ_¾¯(verapamil©Îdiltiazem)
C.¥ª¤ß«Ç°IºÜ-¤ò¦a¶À(digoxin)
D.°ª¦åÀ£¦X¨ÖºC©ÊµÇ°IºÜ(creatinine 3.0 mg/dl)-¶tÂ÷¤lªýÂ_¾¯(nifedipine)
E.¥H¤W¬Ò¾A·í
 
(B) 17.¤U¦C¯f¤H§@¤ú¬ìªvÀø(¬~¤ú¡A©Þ¤ú)®É»Ýµ¹§Ü¥Í¯À§@·P¬V©Ê¤ß¤º½¤ª¢¤§¹w¨¾¡A¦ý¥H¦óªÌ°£¥~
A.¤ß«Ç¤¤¹j¯Ê·l
B.¨Ó¨üÀ˪̴¿¦b¨ä¥LÂåÀø¾÷ºc§@¤ß¶W­µªiÀˬd«á³Q§iª¾¦³"¤G¦yä²æ««¤Î佤Ãö¤£ºò"¡A¦ý¦¹¦¸¶E¹îÁ{§É©|µL©úÅã¤G¦y䳬Âꤣ¥þ
C.¥D°Ê¯ßäÄY­«¯U¯¶
D.ªÎ«p©Êªý¶ë©Ê¤ß¦Ù¯f
E.´«¹L¤H¤u佤¤§¯f¤H
 
(E) 18.¤@¦W60·³±w¦³°ª¦åÀ£¤§¨k©Ê¦]«ùÄò©Ê¯Ý´e¡A«_¦½¦Ü«æ¶E¨D¶E¡A¤ß¹q¹ÏÅã¥Ü¦bV3-6¦³ 2 mm¤§¤Uªi«¬(downward)ST¬q¤U­°¡A¦Ó¥Hnon-ST elevation acute coronart syndrome¶EÂ_¦í°|¡A¦í°|«á¯f¤H¸g¤º¬ìªvÀø«á±µ¨ü«aª¬°Ê¯ß¤¶¤J©ÊªvÀø(PCI)¶¶§Q¥X°|¡A¤U¦CªvÀø¥i§ïµ½¦¹¯f¤H¹w«á¡A­°§C¤ß¦Ù±ð¶ë¤Î¦º¤`­·ÀI¡A¦óªÌ°£¥~
A.Aspirin/clopidogrel
B.Âà¤Æ»Ã¯À§í¨î¾¯(¤×¨ä¦b¥ª¤ß«Ç¥\¯à¤U­°¡A¤ß®g¥X²v(ejection fraction) < 40-45%®É)
C.¤A«¬¥æ·P¯«¸g§í¨î¾¯
D.Statin
E.PCI (Percutaneous coronary intervention)
 
(D) 19.¯Ý³¡X¥úÀˬd²§©ó¨ä¥L³¡¦ì¤§X¥úÀˬd¡A°£¥iµû¦ô¤ß¦åºÞºc³y²§±`¥~¡A¥ç¥i¶¡±µµû¦ô¦å¦æ°Ê¤O¾Ç(hemodynamics)¤§ª¬ºA¡A¨ä¥i¶¡±µµû¦ô(©w©Ê©Î¥b©w¶q)¤§1)-4)¤¤¦å¦æ°Ê¤O¾ÇÅܤƤ§²Õ¦X(A-E)¡A¦óªÌ¬°¥¿½T (1)ªÍÀR¯ß©ÎªÍ°Ê¯ß·¤À£(wedge pressure) (2)ªÍ°Ê¯ßÀ£ (3)ªÍ¦å¬y¶q(¦p¤ßŦ¥ª¥k¤À¬y(left to right shunt)) (4)¥k¤ß©ÐÀ£
A.1+2
B.1+3
C.2+3
D.1+2+3
E.1+2+3+4
 
(C) 20.¤@¦W60·³±w¦³¿}§¿¯f¤§¨k©Ê¡A¦]3­Ó¤ë¨Ó¦³¥ª¤p»L(calf)¶¡·²©Ê¶_¦æ¦Üªù¶E¨D¶E¡C¦¹¯f±wµL°ª¦åÀ£¯f¥v¡AÁ{§É¤WµL«aª¬°Ê¯ß¯e¯f¼x­Ô(¦p¯U¤ß¯g¡A¤ß¦Ù±ð¶ë)¡A¤ßŦ²z¾ÇÀˬd¥¿±`¡A¤â¸}·Å·x¦ÓµLµoÖæ²{¶H¡A¥½±é°Ê¯ß¯ß·i°£¥ªçA°Ê¯ß(popliteal)¡A¨¬­I°Ê¯ß(dorsalis pedis)¤Î«á×H°©°Ê¯ß(posterior tibialis)µy®z¥~¨ä¥L¯ß·i±j«×¥¿±`¡A¥H¤U¦óºØÀˬd¤§²Õ¦X(A-E)¥i½T©w¦³·N¸q¤§¥ª¤UªÏ°Ê¯ß¯Ê¦å(arterial ischemia)?(1)Allen test (2)Straight-leg raising test (3)ABI (ankle/brachial index) (4)Elevation-dependency(¤WÁ|¡A¤U««)test
A.1+3+4
B.1+2+4
C.3+4
D.1+2+3
E.¥H¤W¬Ò¥¿½T
 
(B) 21.¥H¤U¦óºØ¥ð§J(shock)¥i¸g¥Ñ¨ã°ªÄµÄ±©Ê¶EÂ_¤©¥H³B¸m«á¡A¾É­P¥ß¬ñ¨£¼v¦åÀ£¦^¤É¤§®ÄªG¡C¦]¦¹¡A¦b¥ð§J¤§Å²§O¶EÂ_¤W¡A¤@©w¤£¯à¿ù¹L¦¹¶EÂ_
A.§C®e©Ê¥ð§J(hypovolemic shock)
B.¤ß¥]Ån¶ñ¶ë(cardiac tamponade)¾É­P¤§ªý¶ë©Ê¥ð§J(obstructive shock)
C.ªÍ°Ê¯ß®ê¶ë(pulmonary embolism)¾É­P¤§ªý¶ë©Ê¥ð§J(obstructive shock)
D.±Ñ¦å¯g(sepsis)¾É­P¤§¤À§G©Ê¥ð§J(distributive shock)
E.¤ß¦]©Ê¥ð§J(cardiogenic shock)
 
(E) 22.¦³Ãö·P¬V©Ê¤ß¥]½¤ª¢(infective endocarditis)¤§±Ô­z¡A¤U¦C¦óªÌ¬O¥¿½Tªº
A.¤ß¤º½¤ª¢¤§·P¬V¤@¯ë³£¬O¥ª¤ßªº²Óµß¤ñ¥k¤ßªº²Óµß´c¬r
B.¥¿±`ªºÃ¤½¤¤£­P©ó²£¥Í§t¦³¯fµß¡A¦å¤pªO¡AÅÖºû¯À¤§Âإͪ«(vegetation)
C.¯f¤H¤§©è¿m(host degfense)¬O¨M©w±Ñ¦å¯g¤§¥D¦]¡A¥B¬°¤ß¤º½¤ª¢¤§ÃöÁä¦]¯À
D.ų©óµß¦å®ê·|¦b§Ü¥Í¯À¨Ï¥Î«á¤~µo¥Í¡A©Ò¦³¤ß¤º½¤ª¢¯f¤H¡A¤£¥²¥ß¨è¦í°|ªvÀø
E.ªvÀø®ÄªG¤§ªì´Áµû¦ô±o°ò©óÂإͪ«¤§®ø¥¢¡A°h¿N¤Îµß¦å¤§®ø¥¢
 


< ¤E¤Q¤­¦~«×¸ÕÃD¥Ø¿ý >